TEDOPI
Live / Registered — Registered (as of 22 Jul 2025)
What this means for you
Registered since 22 Jul 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97092394
- Registration number
- 7870681
- Mark type
- Stylized text
- Filed
- 26 Oct 2021
- Published for opposition
- 06 Sept 2022
- Registered
- 22 Jul 2025
- Attorney of record
- Patrick J. Jennings
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for cancer treatment, oncology and immunotherapy; Sanitary preparations for medical use; Pharmaceutical products for use in human medicine for cancer treatment, oncology and immunotherapy; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer treatment, oncology and immunotherapy; Vaccines; Medicated serums for cancer treatment, oncology and immunotherapy; Chemical reagents for medical purposes
Owner
- OSE Immunotherapeutics, Nantes, FR
- OSE Immunotherapeutics, Nantes, FR
- OSE Immunotherapeutics, Nantes, FR
Prosecution history
- 22 Jul 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 22 Jul 2025 — REGISTERED-PRINCIPAL REGISTER
- 16 Jul 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Jul 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 27 Jun 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 28 Oct 2024 — USE AMENDMENT FILED
- 27 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 27 Jun 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 25 Nov 2024 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 28 Oct 2024 — TEAS STATEMENT OF USE RECEIVED
- 30 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Apr 2024 — SOU EXTENSION 3 GRANTED
- 29 Apr 2024 — SOU EXTENSION 3 FILED
- 29 Apr 2024 — SOU TEAS EXTENSION RECEIVED
- 28 Oct 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED